Abstract:Background: Hypoxia-inducible factor-1 (HIF-1) is a ubiquitously expressed oxygen-regulated transcription factor composed of alpha and beta subunits. HIF-1 activates the transcription of various genes including those involved in the formation and metastatic growth of hepatocellular carcinoma (HCC). Objectives: To investigate the levels of hepatic and circulating HIF-1 alpha expression in a range of patients with liver disease in order to determine how it can be used in the diagnosis of HCC and in establishing prognosis. Patients and Methods: Total RNA was extracted from a self-controlled HCC and paracancerous specimen. HIF-1 alpha mRNA was amplified by nested RT-PCR and confirmed by sequencing. Tissue HIF-1 alpha was analyzed by immunohistochemistry. The levels of HIF-1 alpha, vascular endothelial growth factor (VEGF), and angiopoietin-2 (Ang-2) expression in the sera of 220 patients with liver disease were quantitatively detected by ELISA. Results: The positive staining of liver HIF-1 alpha was brown and granule-like and was mainly present in the cytoplasm, with lower levels in the nucleus of hepatocytes. Its incidence was 80% in HCC cells and 100% in paracancerous tissues, with no significant difference in HIF-1 alpha expression in relation to tumor number, degree of differentiation, or hepatitis B surface antigen (HBsAg) positivity, but with some correlation between HIF-1 alpha and tumor size. HIF-1 alpha expression was detected in the sera of HCC patients at a significantly higher level than in cases of benign liver disease, with pathological characteristics associated with the levels of circulating VEGF and Ang-2 expression, the size of the tumor, and the level of extrahepatic metastasis, but not With patients' gender, age, or alpha-fetoprotein (AFP) levels. Conclusions: Hepatic HIF-1 alpha expression is associated with the development and prognosis of HCC, and circulating HIF-1 alpha level is a useful marker for HCC diagnosis and prognosis. (C) 2011 Kowsar M.P.Co. All rights reserved.

Erythropoietin Expression in Posterior Fossa Hemangioblastomas

Clinical predictive value of serum angiogenic factor in patients with osteosarcoma.

Histologic and Histogenetic Investigations of Intracranial Hemangioblastomas.

Research of Ultrastructure,Immunohistochemical and Cell Culture in Cerebellar Hemangioblas-tomas

Detection Of Serum Protein Biomarkers For The Diagnosis And Staging Of Hepatoblastoma

Cultivation and identification of the cells from central nervous system hemangioblastomas and its stem cells origin

Three Hematological Indexes That May Serve As Prognostic Indicators in Patients with Primary, High-Grade, Appendicular Osteosarcoma

Expression of Transforming Growth Factor Β 1 in Patients with Hepatocellular Carcinoma and Its Clinical Value

Significance of Detection of EBV-encoded Mrna on Bone Marrow Biopsy Tissues of Hemophagocytic Syndrome

Expression of Erythropoietin and Its Receptor in Oral Squamous Cell Carcinomas

Erythropoietin receptor expression in normal and neoplastic choroid plexus

Identification of Tumorigenic Cells and Implication of Their Aberrant Differentiation in Human Hemangioblastomas

Expressions of Hypoxia-Inducible Factors and Its Related Proteins in Hepatoblastoma

The Relationship among Histopathological Indexes and Prognosis in Patients with Chronic Hepatitis B Infection

The angiogenic growth factors HGF and VEGF in serum and plasma from neuroblastoma patients

A Comprehensive Procedure to Evaluate the in Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay.

The Study of Serum VEGF Level in Head and Neck Squamous Cell Carcinoma

The Relationship of Erythropoietin Overexpression with Von Hippel-Lindau Tumour Suppressor Gene Mutations Between Hypoxia-Inducible Factor-1Α and -2Α in Sporadic Clear Cell Renal Carcinoma

Expression characteristics of hypoxia-inducible factor-1α and its clinical values in diagnosis and prognosis of hepatocellular carcinoma.

[Dynamic Examination of the Serum Erythropoietin Levels Following ABO-incompatible Allogeneic Hematopoietic Stem Cell Transplantation and Its Implications].

THE HBx PROTEIN EXPRESSION IN LIVER CANCER